↓ Skip to main content

Human adult bone marrow-derived stem cells decrease severity of lipopolysaccharide-induced acute respiratory distress syndrome in sheep

Overview of attention for article published in Stem Cell Research & Therapy, March 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter
2 X users
patent
4 patents

Citations

dimensions_citation
42 Dimensions

Readers on

mendeley
67 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Human adult bone marrow-derived stem cells decrease severity of lipopolysaccharide-induced acute respiratory distress syndrome in sheep
Published in
Stem Cell Research & Therapy, March 2014
DOI 10.1186/scrt430
Pubmed ID
Authors

Mauricio Rojas, Nayra Cárdenes, Ergin Kocyildirim, John R Tedrow, Eder Cáceres, Robert Deans, Anthony Ting, Christian Bermúdez

Abstract

Acute respiratory distress syndrome (ARDS) is the most common cause of respiratory failure among critically ill subjects, sepsis and severe bacterial pneumonia being its most common causes. The only interventions that have proven beneficial are protective ventilation strategies and fluid conservation approaches. New therapies are needed to address this common clinical problem. Others and we have previously shown the beneficial effect of infusion of exogenous adult stem cells in different pre-clinical models of ARDS.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 1%
Unknown 66 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 19%
Other 10 15%
Student > Master 7 10%
Student > Ph. D. Student 5 7%
Student > Bachelor 4 6%
Other 8 12%
Unknown 20 30%
Readers by discipline Count As %
Medicine and Dentistry 13 19%
Agricultural and Biological Sciences 9 13%
Biochemistry, Genetics and Molecular Biology 7 10%
Immunology and Microbiology 4 6%
Engineering 4 6%
Other 9 13%
Unknown 21 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 8. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 November 2022.
All research outputs
#4,119,513
of 23,253,955 outputs
Outputs from Stem Cell Research & Therapy
#393
of 2,449 outputs
Outputs of similar age
#40,564
of 225,684 outputs
Outputs of similar age from Stem Cell Research & Therapy
#8
of 30 outputs
Altmetric has tracked 23,253,955 research outputs across all sources so far. Compared to these this one has done well and is in the 82nd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,449 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.1. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 225,684 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 30 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.